22 November 2024

Last updated: Monday 18 November 2024

Research Directory

Letter from Milano: The challenges facing biotech from the coronavirus

Mechanism of immune disablement in HIV infection

Industry and public sector collaborate on recovery

Exploiting the measles vector platform for vaccines

Convalescent plasma hope in SARS-CoV-2 crisis

Biotechs fare relatively well amidst share collapse

COVID-19's logistical impact on advanced therapies

Solving the viral vector bottleneck during a pandemic

What patients really want: involvement

Scientists and industry mobilise against coronavirus